Fig. 8From: Supraphysiologic doses of 17β-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolismUnder normal physiological conditions, E2 maintains microglial stability, and brain metabolic balance, thereby exerting its neuroprotective effects. The supraphysiological doses of estrogen (sE2) treatment activate the ERα/NF-κB pathway, promote the microglial response and brain metabolic imbalance, and then induce the neuroinflammation-mediated neuronal damage, ultimately resulting in depressive-like behaviors in miceBack to article page